Cat. #151411
Anti-ACK [ACK 1F4/9]
Cat. #: 151411
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 3-4 weeks
Target: ACK
Class: Monoclonal
Application: ELISA ; WB
Reactivity: Drosophila
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-ACK [ACK 1F4/9]
- Alternate name: Tyrosine Kinase Non Receptor; Activated Cdc42-Associated Kinase; ACK1
- Research fields: Cancer;Cell biology;Cell signaling and signal transduction;Genetics
- Clone: ACK 1F4/9
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Strain: CD1
- Reactivity: Drosophila
- Host: Mouse
- Application: ELISA ; WB
- Description: ACK is a non-receptor tyrosine kinase, linked to cancer, involved in clathrin-mediated endocytosis. It binds activated cdc42 and inhibits its GTPase activity.
- Immunogen: ACK peptides (drosophila)
- Isotype: IgM
- Myeloma used: Sp2/0-Ag14
Target Details
- Target: ACK
- Target background: ACK is a non-receptor tyrosine kinase, linked to cancer, involved in clathrin-mediated endocytosis. It binds activated cdc42 and inhibits its GTPase activity.
Applications
- Application: ELISA ; WB
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Dry ice
